ACTRN12619001357145尚未招募未知
Randomised double-blinded placebo-controlled trial of 12 weeks duration investigating the tolerability and effectiveness of the Nutrition-Care Gluco-Metabolism Formula on glucose control in pre-diabetic adults.
AProf Dr Karin Ried0 个研究点目标入组 60 人开始时间: 2019年10月3日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •1) Pre-diabetes: FPG: 5.5-7.0 mmol/l and/or PPG: 7.8-11.1 mmol/l
- •Assessment done with Accu-Chek Mobile Blood Glucose Meter (Roche) & disposable strips
排除标准
- •Diagnosed with diabetes, on diabetic medication (e.g. insulin, metformin) or glucose control supplements
- •Diagnosed with chronic illness (cancer, non-fatty-liver), or pregnancy or breastfeeding
- •Taking vitamin C supplements or IVC, and not willing to stop for the length of the trial (as vitamin c can falsify plasma glucose readings)
- •If FPG or PPG are in the diabetic range during screening, the volunteer won’t be eligible to participate in the trial, and will be referred to a GP for follow-up.
- •Have had recent surgery, or planning on any surgery, or change of medication during the 3-4 month study
- •Intolerance or allergies to ingredients in Gluco-Metabolism formula
研究者
相似试验
已完成
不适用
Randomised double-blind, placebo-controlled trial of selenium supplementation in adult asthmaAdult asthmaRespiratoryAsthmaISRCTN31432640Department of Health (UK)200
进行中（未招募）
不适用
Randomized double blinde placebo controlled trial to evaluate the efficacy of N-acetylcystein in patients with chronic pancreatitis and primary sclerosing cholangitis.Chronic pancreatitis and primary sclerosing cholangitisMedDRA version: 15.0Level: PTClassification code 10033649Term: Pancreatitis chronicSystem Organ Class: 10017947 - Gastrointestinal disordersMedDRA version: 15.0Level: PTClassification code 10008609Term: Cholangitis sclerosingSystem Organ Class: 10019805 - Hepatobiliary disordersEUCTR2012-004170-26-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI200
已完成
不适用
Randomised double-blind placebo-controlled trial of intravenous antioxidant therapy in predicted severe pancreatitisAcute pancreatitisDigestive SystemPancreatitisISRCTN56033334Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)225
已完成
不适用
Randomised double-blind placebo-controlled trial of 40 mg/day of Atorvastatin on reduction in severity of SEPSIS in ward patientsInjury, Occupational Diseases, PoisoningSepsisISRCTN64637517Heart of England Foundation Trust (UK)414
已完成
不适用
Randomised double-blind placebo-controlled trial of nasal oxytocin spray in mothers of preterm infantsPregnancy and Childbirth: Breast feedingPregnancy and ChildbirthBreast feedingISRCTN72911449Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)60